RECENT NEWS
Blood test developed to allow early detection of multiple cancers
Researchers at the University of Oxford have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Aignostics publishes results for pathology foundation model
Aignostics has announced research results for a new pathology foundation model developed in collaboration with Mayo Clinic Digital Pathology. The model, built in two months using 1.2 million diverse slide images from Mayo Clinic and Charité – Universitätsmedizin Berlin, establishes a new state-of-the-art for performance across more than twenty public benchmarks.
New partnership to advance sequencing-based IVD neonatal testing
Revvity has announced a strategic agreement to commercialise an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, a life science company democratising access to advanced DNA and multi-omic sequencing solutions.
Proscia’s growth more than doubles as customers adopt enterprise pathology
AI-enabled pathology solutions company Proscia more than doubled its growth in 2024, it has announced. The company enters 2025 having cemented its leadership position, with life sciences organisations and diagnostic laboratories increasingly deploying its Concentriq enterprise pathology platform to advance the next novel therapies and diagnostics.
Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials
Biofidelity, a leader in innovative genomic solutions, and contract research organisation CellCarta, have announced a strategic partnership agreement to utilise Biofidelity’s Aspyre Lung in global clinical trials.
Major update at SWLP’s Croydon laboratory
South West London Pathology (SWLP) has celebrated the installation of new cutting-edge technology from Beckman Coulter at its Essential Services Laboratory at Croydon Hospital, creating one of the most modern, innovative, and efficient clinical blood science services in the country.
IBMS responds to government’s Elective Care Reform Plan
The Institute of Biomedical Science (IBMS) has published a response to the government’s newly published ‘Reforming elective care for patients’, saying that investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all.
New partnership to bring novel neurological diagnostics to the NHS
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning will be used to bring new diagnostics to NHS patients, thanks to a new partnership between University College London Hospitals NHS Foundation Trust (UCLH) and Guilford Street Laboratories (GSL).
Leica Biosystems and Indica Labs announce strategic investment
Leica Biosystems has agreed to make a significant strategic investment in Indica Labs, the two pathology firms have announced. This partnership aims to accelerate AI-enabled companion diagnostics and will also create a new digital pathology platform.
New platelet counting technology to help laboratories prevent diagnosis errors
Risks that can lead to errors in cancer diagnoses could be reduced, as just one benefit of high precision platelet counting technology, launched by international health technology company Mindray.
Bio-Rad leads investment to support gastrointestinal diagnostics
Diagnostics firm Geneoscopy has announced new funding of $105 million, led by Bio-Rad Laboratories, to support the launch of non-invasive colorectal cancer screening test ColoSense, and advance diagnostic innovations for inflammatory bowel disease.
Herpes virus might drive Alzheimer’s pathology, study suggests
University of Pittsburgh researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease.
Novel ‘suspended animation’ blood draw technique
Scientists at the Allen Institute have developed a new approach that keeps blood cells alive in deep freeze, with this new technique promising to expand the reach of cutting-edge single-cell technologies to underserved populations.
New AI tool uses routine blood tests to predict immunotherapy response for many cancers
A recently published study shows that a new blood test combined with an AI tool can better predict if individual cancer patients will benefit from immune checkpoint inhibitors, a type of immunotherapy treatment.
New genetic material for validating H5N1 bird influenza diagnostic tests
The USA’s National Institute of Standards and Technology (NIST) has developed a synthetic, non-hazardous genetic material to support the development and validation of diagnostic tests for the H5N1 virus - commonly known as bird influenza.
Anthony Harnden takes up position as MHRA Chair
Professor Anthony Harnden has taken up the position as Chair of the Medicine and Healthcare products Regulatory Agency (MHRA), from January 2025.
Government expanding CDCs to tackle NHS waiting lists
Prime Minister Sir Keir Starmer has unveiled the government’s Elective Reform Plan, which aims to end NHS backlogs by offering up to half a million more appointments each year thanks to greater access to Community Diagnostic Centres and new or expanded surgical hubs.
Dr Sarah Pitt confirmed as IBMS President Elect
The Institute of Biomedical Science (IBMS) has announced Dr Sarah Pitt CSci FIBMS as its new President Elect, having taken office on 1 January to support Joanna Andrew in her second and final year as President.
Early cancer diagnosis in England reaches highest ever level
The proportion of patients being diagnosed with cancer at an early stage in England has risen to its highest ever level, according to new NHS figures.
Davos Alzheimer’s Collaborative announces new partnerships for Alzheimer’s disease blood biomarker validation
The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, has announced it will work with Janssen Research & Development, a Johnson & Johnson company, and Beckman Coulter Diagnostics, two leading pharmaceutical and diagnostics companies, to advance the assay validation of blood-based biomarkers for Alzheimer’s disease for global use in diverse populations.
Latest Issues
Global Headquarters
Advanced Instruments, LLC
Two Technology Way
Norwood, MA 02062, United States
Phone: +1 800-225-4034
Advanced Instruments has been a leading developer and manufacturer of analytical instruments and services for the clinical, biopharmaceutical, and food & beverage industries for more than 65...
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025
Distinguishing tumour tissue from normal tissue
Online
8 July, 2025
Introduction to direct immunofluorescence webinar
Online
10 July, 2025
Annual SHOT Symposium
Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025
Introduction to immunocytochemistry webinar
Online
15-16 July, 2025